Moreover, Needham’s analyst sees retail-driven market trends, particularly meme stock trading, as beneficial for Robinhood. The company has a proven track record of capitalizing on trends in the ...

Biogen downgraded to Hold by Needham amid projected flat revenues until 2026. Leqembi and other new product sales show ...

John Todaro, analyst at Needham, joins CNBC's 'Money Movers' to discuss why his firm is upgrading Robinhood to a buy, what ...

Herlda Senhouse, Massachusetts' oldest resident at 113, passed away peacefully. Known for her activism, she leaves a legacy ...

A man has pleaded guilty to obstructing the investigation into an arson investigation involving fires believed to have been set by his brother at multiple Boston-area Jewish institutions five years ...

Needham downgraded Biogen (BIIB) to Hold from Buy without a price target The firm does not see a meaningful source of upside for the shares ...

Needham upgrades Robinhood Markets to Buy, citing potential benefits from SEC changes under a second Trump administration.

Biogen (BIIB – Research Report) received a Hold rating and price target from Needham analyst Ami Fadia today. The company’s shares closed last Friday at $159.99. Don't Miss our Black Friday Offers: ...

We recently compiled a list of the 15 AI Stocks That Are Dominating Headlines. In this article, we are going to take a look ...

A year ago, Needham’s Greta Hammer was outside the ropes watching the MIAA Meet of Champions. On Saturday at Willard Park, ...

On Friday, Revolution Medicines Inc (RVMD) stock saw a decline, ending the day at $55.13 which represents a decrease of $-2.24 or -3.90% from the prior close of $57.37. The stock opened at $56.97 and ...

NEEDHAM -- While their offense certainly left its mark, it was No. 4 Needham’s defense that earned them the 31-7 win over No.